Source: Outsourcing-Pharma

Chiltern: Chiltern acquisition improves competitiveness of offerings, says Covance CEO

LabCorp has acquired Chiltern for $1.2bn to create a global contract research organization (CRO) with more than 20,000 employees.

Read full article »

Chiltern's Competitors | Chiltern's News | Chiltern's Financials

Followers on Owler

1,065

Est. Annual Revenue

$500M-1.0B

Est. Employees

1.0-5.0K

CEO

Update CEO

CEO Approval Rating

- -/100

Chiltern is a contract research organization that provides clinical development services for diagnostics, pharmaceuticals and biotechnology industries.